KEY FEATURES
| Full Name | Adrenergic Receptor Alpha 1A |
|---|---|
| Synonym | ADR-A1A; ADRA1-A; ADRA1C; ADRA1L1; Alpha1AAR; Alpha 1a-Adrenoceptor |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human ADRa1A in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ADRa1A. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ADRa1A and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ADRa1A, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ADRa1A. You can calculate the concentration of Human ADRa1A in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human ADRa1A ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.99 | 2.26 | 9.11 | 1.02 | 2.26 | 9.35 |
| Standard deviation | 0.06 | 0.09 | 0.38 | 0.06 | 0.09 | 0.31 |
| CV(%) | 5.9 | 4.1 | 4.2 | 6.26 | 4.2 | 3.34 |
RECOVERY
The recovery of Human ADRa1A spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-100 | 95 |
| EDTA plasma (n=8) | 88-102 | 95 |
| Cell culture media (n=8) | 89-103 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ADRa1A in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Pathways associated with ELISA Kit
| AMPK Signaling Pathway | AMPK Signaling Pathway |
| Adrenergic Signaling In Cardiomyocytes Pathway | Adrenergic Signaling In Cardiomyocytes Pathway |
| Adrenoceptors Pathway | Adrenoceptors Pathway |
| Amine Ligand-binding Receptors Pathway | Amine Ligand-binding Receptors Pathway |
| Calcium Regulation In The Cardiac Cell Pathway | Calcium Regulation In The Cardiac Cell Pathway |
| Calcium Signaling Pathway | Calcium Signaling Pathway |
Diseases associated with ADRa1A ELISA Kit
| Hypertension | publications with ADRa1A and Hypertension |
| Heart Diseases | publications with ADRa1A and Heart Diseases |
| Hyperplasia | publications with ADRa1A and Hyperplasia |
| Prostatic Hyperplasia | publications with ADRa1A and Prostatic Hyperplasia |
| Prostatic Diseases | publications with ADRa1A and Prostatic Diseases |
| Ischemia | publications with ADRa1A and Ischemia |
| Heart Failure | publications with ADRa1A and Heart Failure |
| Urologic Diseases | publications with ADRa1A and Urologic Diseases |
| Pain | publications with ADRa1A and Pain |
| Hypotension | publications with ADRa1A and Hypotension |
Organs/Tissues associated with ADRa1A ELISA Kit
| Brain | publications with ADRa1A and Brain |
| Liver | publications with ADRa1A and Liver |
| Testis | publications with ADRa1A and Testis |
| Uncharacterized Tissue | publications with ADRa1A and Uncharacterized Tissue |
